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e show here that 
 
 
 
1
 
 integrins selectively modulate
insulin-like growth factor type I receptor (IGF-IR)
signaling in response to IGF stimulation. The 
 
 
 
1A
 
integrin forms a complex with the IGF-IR and insulin receptor
substrate-1 (IRS-1); this complex does not promote IGF-I
mediated cell adhesion to laminin (LN), although it does
support IGF-mediated cell proliferation. In contrast, 
 
 
 
1C
 
, an
integrin cytoplasmic variant, increases cell adhesion to LN
in response to IGF-I and its down-regulation by a ribozyme
prevents IGF-mediated adhesion to LN. Moreover, 
 
 
 
1C
 
completely prevents IGF-mediated cell proliferation and
W
 
tumor growth by inhibiting IGF-IR auto-phosphorylation in
response to IGF-I stimulation. Evidence is provided that
the 
 
 
 
1
 
 cytodomain plays an important role in mediating 
 
 
 
1
 
integrin association with either IRS-1 or Grb2-associated
binder1 (Gab1)/SH2-containing protein-tyrosine phosphate
2 (Shp2), downstream effectors of IGF-IR: speciﬁcally, 
 
 
 
1A
 
associates with IRS-1 and 
 
 
 
1C
 
 with Gab1/Shp2. This study
unravels a novel mechanism mediated by the integrin cyto-
plasmic domain that differentially regulates cell adhesion
to LN and cell proliferation in response to IGF.
 
Introduction
 
Neoplastic prostate growth and metastasis are regulated by
interactions between cells and the surrounding ECM pro-
teins (Parise et al., 2000). Members of the laminin (LN)
family are the first ECM proteins synthesized during embryonic
development (Ekblom et al., 2003). LN-1, composed of
 
 
 
1
 
 
 
1
 
 
 
1
 
 subunits, is an important component of the epithelial
basement membranes, and contributes to epithelial cell
adhesion and polarization (Malinda and Kleinman, 1996).
LN-1 plays an important role in regulating the functions of
normal and malignant human prostate epithelial cells (Bello-
DeOcampo et al., 2001). LN interactions with several cells
are mediated by integrins (Mercurio, 1995). Integrins are
heterodimeric receptors consisting of an 
 
 
 
 and 
 
 
 
 subunit
mediating cell–cell and cell–ECM interactions (Hynes, 2002).
Members of the 
 
 
 
1
 
 subfamily and the 
 
 
 
6
 
 
 
4
 
 integrin have
been reported to function as LN receptors and to play a
role in tumor growth (Juliano, 1993; Mercurio, 1995; Co-
lognato and Yurchenco, 2000).
The integrin cytoplasmic domains modulate several signal
transduction pathways (Fornaro and Languino, 1997). The
cytoplasmic domain of 
 
 
 
1
 
 exists in five different spliced
forms and is known in its most widely expressed form, i.e.,
 
 
 
1A
 
, to modulate cell proliferation and migration as well as
receptor localization (Fornaro and Languino, 1997). The
 
 
 
1C
 
 integrin, an alternatively spliced variant of the 
 
 
 
1
 
 sub-
family that contains a unique 48–amino acid sequence in its
cytoplasmic domain inhibits normal and cancer cell prolifer-
ation (Fornaro and Languino, 1997). This cytoplasmic variant
is expressed in nonproliferative, differentiated epithelium
and is selectively down-regulated in prostate and breast car-
cinoma (Fornaro and Languino, 1997; Manzotti et al., 2000).
Insulin-like growth factors (IGFs) and the IGF type I re-
ceptor (IGF-IR) are important modulators of growth and
differentiation, play a crucial role in the establishment and
maintenance of the transformed phenotype (Baserga, 2000),
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and are potential targets for anticancer treatment (Surmacz,
2003). The IGF axis appears to contribute to prostate
cancer progression, but the mechanisms responsible for
this process have not been studied (Reiss et al., 1998).
IGF-I and IGF-II bind to IGF-IR and stimulate several
signaling pathways including phosphatidylinositol 3-kinase
(PI 3-kinase) and MAPK (Valentinis and Baserga, 2001;
LeRoith and Roberts, 2003); both pathways are also known
to be activated by integrin engagement (Damsky and Ilic,
2002). IGF-I induces association of 
 
 
 
1
 
 integrins and IGF-IR
and increases adhesion of myeloma cells to fibronectin
(FN; Tai et al., 2003). It has also been shown to increase
adhesion of breast cancer cells to LN and this increase is
inhibited by 
 
 
 
-IR3, an antibody to the IGF-IR (Dunn et
al., 1998).
The present work unravels a novel mechanism that regu-
lates cell adhesion to LN-1 in response to IGF without af-
fecting cell proliferation or tumor growth and is mediated by
the association of 
 
 
 
1
 
 integrins with IGF-IR and with IGF-IR
downstream effectors.
 
Results
 
IGFs stimulate adhesion to LN-1 of 
 
 
 
1C
 
-, but not of
 
 
 
1A
 
-expressing cells
 
To investigate the effect of 
 
 
 
1
 
 integrins on IGF-IR–medi-
ated functions, we used CHO and PC3 cells expressing ei-
ther 
 
 
 
1A
 
 or 
 
 
 
1C
 
 integrin cytoplasmic variants under the con-
trol of a tetracycline (tet)-regulated promoter (Fornaro et al.,
2000, 2003). As shown in Fig. 1 (A and B), addition of IGF-
II caused a eightfold increase in adhesion to LN-1 of CHO
cell transfectants expressing 
 
 
 
1C
 
 (
 
 
 
tet) compared with cells
that did not express 
 
 
 
1C
 
 (
 
 
 
tet). IGF-II had no effect on cell
adhesion to FN. Preincubation of cells with Ab to IGF-II
prevented IGF-II mediated increased adhesion to LN-1 in
 
 
 
1C
 
 expressing cells (Fig. 1 A). In contrast, IGF-II had no ef-
fect on cell adhesion in the presence of exogenously ex-
pressed 
 
 
 
1A
 
 integrin (Fig. 1, A and B). Comparable levels of
surface expression of exogenous 
 
 
 
1A
 
 and 
 
 
 
1C
 
 evaluated using
an mAb to human 
 
 
 
1
 
, TS2/16, were consistently observed
(Fig. 1 C). Flow cytometry (FACS
 
®
 
) analysis performed us-
Figure 1. IGF stimulates adhesion to 
LN-1 of  1C-expressing cells.  1C-CHO 
(clones 16.3 and 16.4) and  1A-CHO 
(clones 10.18 and 10.2) clones were 
cultured in the absence (A) or in the 
presence (B) of tet for 48 h. Cells were 
labeled using 
51Cr-sodium chromate for 
1 h at 37 C. 
51Cr-labeled cells were incu-
bated in the presence or in the absence 
of purified rabbit Ab to IGF-II or ni-rIgG 
for 1 h on ice. Cells were plated on BSA, 
LN-1, or FN at 37 C for 2 h in the pres-
ence or in the absence of IGF-II. Attached 
cells were washed, lysed, and the amount 
of 
51Cr associated with the attached cells 
was measured by liquid scintillation 
counting. Data are expressed as mean   
SEM. (C) Representative  1C-CHO and 
 1A-CHO clones were cultured in the 
absence or in the presence of tet for 48 h 
and analyzed by FACS
® using a  1 inte-
grin Ab TS2/16 specific to human  1 or 
7E2 specific to hamster  1 or, as negative 
control, 12CA5. 
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ing mAb 7E2 (Brown and Juliano, 1985) revealed compara-
ble levels of expression of endogenous 
 
 
 
1
 
 integrin in the 
 
 
 
1A
 
and 
 
 
 
1C
 
 transfectants (Fig. 1 C), thus suggesting that the
observed effect on cell adhesion to LN-1 was not due to
changes in endogenous 
 
 
 
1
 
 integrin levels.
Because our previous studies have shown that the 
 
 
 
1C
 
 vari-
ant is down-regulated in prostate carcinoma (Fornaro et al.,
1999; Moro et al., 2004), we analyzed the ability of normal
or neoplastic prostate cells to adhere to LN-1 in response to
IGF-I. IGF-I stimulated adhesion to LN-1 of normal hu-
man prostate epithelial cells (PrEC), but did not increase ad-
hesion to LN-1 of human prostate cancer, PC3, cells (Fig. 2
A). To further confirm that IGF-stimulated cell adhesion to
LN-1 is mediated by 
 
 
 
1C
 
 integrin in prostate epithelial cells,
we used 267B1, a nontumorigenic prostate epithelial cell
line, that expresses 
 
 
 
1C
 
 (Fig. 2 B) and adheres to LN-1 (not
depicted). We down-regulated the expression of 
 
 
 
1C
 
 in
267B1 cells using a ribozyme (RZ) specific for 
 
 
 
1C
 
 (RZ-
 
 
 
1C
 
;
Fig. 2 C). The RZ specifically inhibited 
 
 
 
1C
 
 expression but
did not have any effect on the levels of other proteins, such
as Akt or IGF-IR (Fig. 2 C). As shown in Fig. 2 D, down-
regulation of 
 
 
 
1C
 
 integrin completely prevented IGF-I stim-
ulated cell adhesion to LN-1, but did not have any effect on
cell adhesion to FN.
Re-expression of 
 
 
 
1C
 
 integrin in PC3 cells caused a signifi-
cant increase in cell adhesion to LN-1 in the presence of IGF-
II (Fig. 3 A) and IGF-I (Fig. 3 C). In contrast, IGF-II had no
effect on cell attachment to LN-1 in 
 
 
 
1A
 
 expressing cells (Fig.
3 B). Similarly, IGF-I caused an increase in cell adhesion to
LN-1 in the presence of 
 
 
 
1C
 
, but not of 
 
 
 
1A
 
 integrin (Fig. 3
C). Because both IGF-I and IGF-II bind IGF-IR (Baserga,
2000) and gave comparable results (not depicted), they were
used interchangeably. Cell adhesion to LN-1 stimulated by
IGF-I was inhibited by an Ab to LN-1 (Fig. 3 D) and no dif-
ferences between 
 
 
 
1C
 
 and 
 
 
 
1A
 
 expressing cells were observed
when the cells attached to FN (Fig. 3, A–D). In conclusion,
cells expressing elevated levels of 
 
 
 
1C
 
 show a small, enhanced
adhesion to LN-1, which is significantly stimulated in the
presence of IGF-I or IGF-II. In contrast, cells expressing 
 
 
 
1A
 
retain the low baseline level of adhesion to LN-1, and their
adhesion is not responsive to IGFs.
The 
 
 
 
6
 
 
 
1
 
 integrin is the major LN-1 receptor and inhibi-
tion of 
 
 6 1 functions prevents acinar morphogenesis in
prostate epithelial cells (Cooper et al., 1991; Shaw and Mer-
curio, 1993; Mercurio, 1995; Bello-DeOcampo et al., 2001).
As shown in Fig. 3 E, addition of an inhibitory Ab to  6
(GoH3; Sonnenberg et al., 1987) prevented IGF-I mediated
increased cell adhesion to LN-1 in PC3- 1C transfectants.
Neither GoH3 nor normal rat IgG (rtIgG) inhibited cell ad-
hesion to FN (Fig. 3 F). Comparable levels of surface expres-
sion of exogenous  1A or  1C in PC3 cells were consistently
observed in all experiments after tet removal (Fig. 3 G). As
shown in Fig. 3 G, induction of exogenous  1A or  1C expres-
sion did not change the levels of endogenous  6 integrin as
analyzed by FACS
® using GoH3. In conclusion, the  6 inte-
grin is the predominant receptor that mediates IGF-stimu-
lated cell adhesion to LN-1 of  1C expressing cells.
Expression of  1C inhibits IGF-stimulated cell 
proliferation and tumor growth
We investigated whether  1 integrins could interfere with
PC3 cell proliferative response to IGFs. We found that both
IGF-I and IGF-II increased PC3 cell proliferation in the pres-
ence of  1A, whereas expression of  1C prevented IGF-I or
Figure 2. Down-regulation of  1C expression in 267B1 cells inhibits 
IGF-I–stimulated cell adhesion to LN-1. (A) PrEC and PC3 cells were 
serum starved for 12 h, detached, and plated on LN-1 or FN at 37 C 
for 2 h in the presence or in the absence of IGF-I. Cell adhesion was 
analyzed by crystal violet staining. (B) pRNS-1-1 and 267B1 cells 
were lysed and immunoblotted with mAb to  1C or normal IgM. 
(C) 267B1 cells were transiently transfected with pBJ1-RZ- 1C or 
vector alone, lysed, and immunoblotted with mAb to  1C, Ab to Akt, 
or Ab to IGF-IR. CHO- 1C cell lysate was used as a positive control. 
(D) 267B1 cells were transiently transfected with pBJ1-RZ- 1C or 
vector alone were detached and seeded on BSA or LN-1 or FN-
coated plates at 37 C for 2 h in the presence or in the absence of 
IGF-I and stained with  -gal. Cell attachment was expressed as 
percentage of cells transfected with vector and attached to LN-1 
in the absence of IGF-I, set at 100. Data are expressed as mean   
SEM. The experiments were repeated at least twice with similar results.410 The Journal of Cell Biology | Volume 166, Number 3, 2004
IGF-II stimulation of cell proliferation (Fig. 4 A). Based on
the finding that  1 integrin is essential for tumor growth
(Bloch et al., 1997) and IGF-IR promotes transformation
(Baserga, 2000), we hypothesized that  1C would prevent tu-
mor growth given its ability to inhibit IGF-stimulated cell
proliferation. Because prostate cancer cells form tumors in an
IGF-IR–dependent manner when injected subcutaneously in
nude mice (Burfeind et al., 1996; Reiss et al., 1998), we in-
jected PC3 cell transfectants expressing either  1A or  1C and
followed tumor growth. Tumor formation by PC3- 1A cells
was not affected by the presence or absence of tet in the drink-
ing water and there were no differences in tumor formation
and growth at all the examined time points (Fig. 4 B). The tu-
mors that formed in the tet-deprived animals injected with
PC3- 1C cells were significantly smaller in size compared with
those in animals given tet (Fig. 4 C). PC3- 1C cells showed
tumor formation at significantly later time points indicating
that the cells were alive (not depicted). These data show that
 1C significantly reduced prostate cancer cell proliferation and
tumor growth, in vivo.
IGF-IR and  1C act synergistically to support cell 
adhesion to LN-1
To analyze the role of IGF-IR in mediating cell adhesion to
LN-1, we used R  cells derived from mouse embryos with a
targeted disruption of the IGF-IR gene, and R  cells are ob-
Figure 3.  1C enhances IGF-I– and II–mediated PC3 cell adhesion to LN-1. (A–D)  1A- and  1C-PC3 clones were cultured in the presence or 
in the absence of tet for 48 h. Cells were detached and plated on BSA or LN-1 or FN at 37 C for 2 h in the presence of IGF-II (A and B), of IGF-I 
(C and D), or of Ab to LN-1 (D) or ni-rIgG (D). In A, the differences in cell adhesion to LN-1 in the presence or in the absence of tet are statistically 
significant (*P   0.03). In C, the differences in cell adhesion to LN-1 between  1A and  1C expressing cells are statistically significant (*P   
0.024). The experiments were repeated at least three times with similar results using two clones each of  1A- and  1C-PC3 cells. (E and F)  1A- 
and  1C-PC3 clones were cultured in the presence or in the absence of tet for 48 h. Cells were serum starved for 12 h, detached, and plated 
on LN-1 (E), FN or BSA (F) in serum-free medium at 37 C for 2 h in the presence or in the absence of IGF-I or GoH3 or rtIgG. Cell adhesion 
was analyzed by crystal violet staining. Data are expressed as mean   SEM. (G) Surface expression of endogenous or exogenous  1A or  1C 
integrin or endogenous  6 integrin was analyzed in PC3 cells by FACS
® using Ab to human  1, TS2/16, chicken  1, W1B10,  6, GoH3; or, 
as negative controls, mIgG, rtIgG, or 12CA5. 1 integrins and IGF-IR role in cell adhesion | Goel et al. 411
tained by transfection of IGF-IR in R  cells (Sell et al.,
1994). R  and R  cells were transiently transfected using
human  1A or  1C integrin cDNA. The expression levels of
the transfected integrins were analyzed by FACS
® and found
to be comparable (Fig. 5 A). Expression of  1C, but not of
 1A integrin in R  cells significantly increased cell adhesion
to LN-1 and this increase was further stimulated by IGF-II
(Fig. 5 B). Transfection of  1C integrin in R  cells showed
no increase in cell adhesion to LN-1, suggesting that  1C in-
tegrin alone is unable to bind to LN-1 (Fig. 5 C). Compar-
ing cell adhesion of R  and R  cells to LN-1 and FN, re-
vealed that these cells adhere equally well to LN-1 and FN
(not depicted). This excludes the possibility that IGF-IR
alone is sufficient to stimulate cell adhesion to LN-1. These
results show that neither  1A alone, nor  1C alone, nor IGF-
Figure 4.  1A and  1B differentially affect IGF-mediated cell 
proliferation and tumor growth. (A)  1A- and  1C-PC3 clones were 
cultured in the absence of tet for 48 h. Cells were plated on a 96-
well plate in serum-free medium with or without IGF-I or IGF-II at 
37 C. After 72 h of incubation, cell proliferation was analyzed using 
SRB. As control, sulforhodamine B (SRB) incorporation of cells 
attached to FN-coated substrates was measured in parallel (black 
bars). (B and C) PC3- 1A (B) and PC3- 1C (C) clones were injected 
subcutaneously in athymic male Balb/c mice. Mice were given 
water supplemented with either 5% sucrose to induce  1A or  1C 
expression, or 5% sucrose plus 100  g/ml tet. The graphs show 
kinetics of tumor growth. Tumor growth is expressed as tumor volume 
in cubic millimeters. Data are the mean   SEM of 10 animals per group. 
*P   0.001 at 10, 12, 14, and either 16 or 17 d from injection. 
These experiments were repeated three times with similar results.
Figure 5. IGF-IR and  1C act synergistically to support cell adhesion 
to LN-1. (A) R  and R  cells were transiently transfected with human 
 1A or  1C. Surface expression of  1A or  1C was analyzed by FACS
® 
using TS2/16 or 12CA5 as a negative control. Thick line, TS2/16; thin 
line, 12CA5. (B) R  cells transiently transfected with  1A or  1C were 
detached and seeded on BSA or LN-1–coated plates at 37 C for 2 h in 
the presence or in the absence of IGF-II and stained with  -gal. (C) R  
and R  cells (10
6) transiently transfected with  1A or  1C were incu-
bated with or without P4C10 (a- 1) or 1C10 (neg-cont) on ice for 1 h. 
Cells were plated on BSA or LN-1 or FN at 37 C for 2 h and stained 
with  -gal. Attachment of cells transfected with  1-integrin cDNA was 
expressed as percentage of cells transfected with pBJ (B) or pBJ- 1A (C) 
that were attached to LN-1, set at 100. The experiments were repeated 
at least twice with similar results. Data are expressed as mean   SEM.412 The Journal of Cell Biology | Volume 166, Number 3, 2004
IR alone, nor IGF-IR and  1A support cell adhesion to LN-1,
and that the synergistic activity of both IGF-IR and  1C is
required to support cell adhesion to LN-1.
 1C decreases IGF-stimulated tyrosine phosphorylation 
of IGF-IR and  1A–IGF-IR association
Because  1 integrins have been shown to associate with IGF-
IR (Tai et al., 2003), we investigated whether  1A or  1C
would differentially associate with IGF-IR using PC3 trans-
fectants. The results showed that  1A, but not  1C associates
with IGF-IR (Fig. 6 A). IGF-IR belongs to the family of re-
ceptor tyrosine kinases that undergo tyrosine phosphoryla-
tion upon ligand binding (LeRoith and Roberts, 2003).
IGF-I increased IGF-IR tyrosine phosphorylation in  1A ex-
pressing PC3 cells, whereas expression of  1C significantly
prevented IGF-stimulated tyrosine phosphorylation of IGF-
IR resulting in inhibition of association between  1A and
IGF-IR (Fig. 6, B and C).
To analyze whether the  1C integrin unique 48–amino
acid cytoplasmic domain has an inhibitory effect on IGF-
IR– 1A association, we used CHO transfectants expressing
full-length  1A integrin or the  1COM mutant, that pre-
serves the sequence shared by  1A and  1C integrins or the
 1C 802 truncated mutant shown in Fig. 6 E. As expected,
expression of full-length  1A integrin showed a strong asso-
ciation with IGF-IR (Fig. 6 D). The  1COM mutant re-
tained the property to associate with IGF-IR showing that
the common sequence between  1A and  1C integrin is only
partially responsible for this association. The  802 signifi-
cantly inhibited the association with IGF-IR, showing that
the 778–802 domain mediates the  1C inhibitory effect on
the association between IGF-IR and  1A. The results sug-
gest an important role of the  1 cytoplasmic domain in the
regulation of IGF-IR tyrosine phosphorylation and of  1A–
GF-IR association.
 1A associates with and supports tyrosine phosphorylation 
of IRS-1, whereas  1C associates with and supports 
tyrosine phosphorylation of Gab1 and Shp2
Upon tyrosine phosphorylation, IGF-IR becomes the dock-
ing site for SH2 domain-containing proteins (LeRoith and
Roberts, 2003), such as insulin receptor substrate-1 (IRS-1).
IRS-1 is known to mediate several functions, predominantly
proliferation and transformation, stimulated by the IGF-IR
(Surmacz, 2003). Grb2-associated binder1  (Gab1) is an-
other downstream effector of IGF-IR, as well as of the insu-
lin receptor, and shares functional and structural homology
with IRS-1 (Winnay et al., 2000; Gu and Neel, 2003). To
investigate whether the  1 cytoplasmic domain would af-
fect the downstream signaling proteins via direct association
with  1A or  1C, we used CHO transfectants, where  1A was
found to be associated with the IGF-IR (Fig. 7 A, top). Our
results showed that IRS-1 associates with  1A and that  1C
associates with Gab1 (Fig. 7 B). Cell transfectants expressed
similar levels of exogenous  1 integrins (Fig. 7 A, bottom),
IRS-1, or IGF-IR (not depicted).
To study the effect on IRS-1 or Gab1 tyrosine phosphory-
lation of the differential association of  1A and  1C with
IRS-1 or Gab1 respectively, we used CHO transfectants. As
shown in Fig. 7 C, IGF-I increased the tyrosine phosphory-
lation of IRS-1 in  1A expressing CHO cells, whereas expres-
sion of  1C significantly prevented IGF-stimulated tyrosine
phosphorylation of IRS-1. In contrast, we found that expres-
Figure 6.  1C inhibits IGF-IR tyrosine phosphorylation and  1A 
association with IGF-IR.  1A- and  1C-PC3 clones were cultured in 
the presence or in the absence of tet for 48 h, stimulated with IGF-I 
for 10 min at 37 C, lysed. Exogenous  1 was immunoprecipitated 
using CSAT (A) and endogenous  1 using K-20 (C). In A, immuno-
blotting (IB) was performed using CSAT or Ab to IGF-IR- . (B) Cells 
were incubated with or without IGF-I for 0, 5, 10, and 20 min in 
suspension at 37 C. Immunoprecipitation was performed using Ab 
to IGF-IR- . Immunoprecipitates were separated on SDS-PAGE and 
immunoblotted with PY20 or Ab to IGF-IR- . In C, the endogenous 
 1 immunoprecipitates were reprecipitated and immunoblotted 
with Ab to IGF-IR- . (D) CHO clones expressing the full-length  1A 
integrin or  1COM or  1C 802 truncated mutant were cultured for 
48 h. Cells were lysed and proteins were immunoprecipitated with 
K-20. The immunocomplexes were dissociated and proteins were 
reimmunoprecipitated with Ab to IGF-IR or ni-rIgG. The immuno-
precipitates were separated using SDS-PAGE and immunoblotted 
with Ab to IGF-IR. (E) Schematic representation of  1C cytoplasmic 
domain deletion mutants. The experiments were repeated at least 
twice with similar results. 1 integrins and IGF-IR role in cell adhesion | Goel et al. 413
sion of  1C significantly increased tyrosine phosphorylation
of Gab1 (Fig. 7 D). Gab1, upon tyrosine phosphorylation,
recruits and activates SH2-containing protein-tyrosine phos-
phate 2 (Shp2) phosphatase that causes dephosphorylation
of Shp2 substrates including IGF-IR (Neel et al., 2003). In
 1C, but not in  1A expressing cells, Gab1-associated Shp2
showed increased tyrosine phosphorylation levels (Tyr542)
as evaluated by mobility shift assay and using a phospho-Ab
specific to Shp2 (Fig. 7 E).
To explore the role of Shp2 in IGF-I mediated cell ad-
hesion to LN-1, CHO cells expressing  1A or  1C were
transiently transfected with either HA-tagged wt-Shp2 or
FLAG-tagged Shp2 C/S, a dominant negative form of Shp2
(Zhang et al., 2002). As shown in Fig. 7 F, enhanced cell ad-
hesion to LN-1 in the presence of IGF-I in  1C expressing
CHO cells was completely prevented by transfection of
Shp2 C/S, as compared with vector alone or wt-Shp2. The
expression levels of the transfected wt-Shp2 or Shp2 C/S
cDNAs were analyzed in cell lysates and found comparable
in  1A and  1C expressing cells (Fig. 7 G).
Overall, these data show that  1A and  1C differentially as-
sociate with IRS-1 and Gab1 and that Shp2 activation is re-
quired for cell adhesion to LN in response to IGFs.
PI 3-kinase mediates IGF-stimulated adhesion to LN-1
PI 3-kinase is a downstream effector that mediates IGF-IR
as well as integrin-stimulated signaling; PI 3-kinase activa-
tion requires Shp2 in some pathways activated by receptor-
tyrosine kinases such as IGF-IR and PDGF receptor, but
not by others such as EGF receptor (Reiss et al., 2001; Neel
et al., 2003; Tai et al., 2003). We investigated the role of PI
3-kinase in cell adhesion stimulated by IGF-II in cell trans-
fectants expressing  1C integrin. We transiently transfected
CHO clones expressing  1C integrin with dominant nega-
Figure 7.  1A associates with and supports tyrosine phosphorylation 
of IRS-1, whereas  1C associates with and supports tyrosine phos-
phorylation of Gab1 and Shp2. (A) CHO clones expressing either  1C 
or  1A integrin were lysed and  1 integrin was immunoprecipitated 
using K-20. (A) The  1 immunoprecipitates were reprecipitated with 
Ab to IGF-IR or ni-rIgG and immunoblotted with polyclonal Ab to 
IGF-IR (top). As control, proteins from CHO cell lysates were immuno-
precipitated with Ab to  1 integrin or ni-mIgG and immunoblotted 
with Ab to  1 integrin (Ab13, bottom). (B) CHO clones expressing 
either  1C or  1A integrin were incubated with or without IGF-I for 10 
min, lysed, and proteins were immunoprecipitated with Ab to  1 integrins (K-20) and immunoblotted with Ab to IRS-1 (top), Gab1 (middle), or  1 
integrin (bottom). (C–E) CHO clones expressing either  1C or  1A integrin were incubated with or without IGF-I for 10 min, lysed, and proteins 
were immunoprecipitated with Ab to IRS-1 (C) or Gab1 (D and E). Immunoprecipitates were separated using SDS-PAGE and immunoblotted 
with Ab to p-Tyr (PY20) (C and D), IRS-1 (C), Gab1 (D and E), Shp2 (E), or phospho-Shp2 (E). (F)  1A- and  1C-CHO clones were transiently 
transfected with wt-Shp2 or Shp2 C/S or vector alone. Cells were then cultured in the absence of tet for 48 h, plated on LN-1 and incubated 
for 2 h at 37 C in the presence or in the absence of IGF-I. After incubation, cells were fixed and stained with  -gal. Attachment of cells trans-
fected with wt-Shp2 or Shp2 C/S cDNA was expressed as percentage of the number of attached cells transfected with vector alone, set at 100 in 
the absence of IGF-I. Data are expressed as mean   SEM. (G)  1A- and  1C-CHO clones were transiently transfected with either HA-tagged 
wt-Shp2 or FLAG-tagged Shp2 C/S or vector alone. ERK1 was used as loading control. Cells were lysed after 48 h and immunoblotted with Ab to 
HA for wt-Shp2 or Ab to FLAG for Shp2 C/S. The experiments were repeated at least three times with similar results. White lines indicate that 
intervening lanes have been spliced out. 414 The Journal of Cell Biology | Volume 166, Number 3, 2004
tive form of p85 (DNp85), wild-type p85 (wt-p85), or vec-
tor alone. As shown in Fig. 8 A, IGF-II stimulated cell ad-
hesion to LN-1 in  1C expressing cells in either vector or
wt-p85 transfected cells, but cell adhesion to LN-1 was sig-
nificantly inhibited upon transfection of DNp85. In our
previous work, we have shown that antibody-mediated en-
gagement of  1 integrins activates the PI 3-kinase/Akt path-
way (Fornaro et al., 2000). We found threefold higher acti-
vation of Akt, a PI 3-kinase downstream signaling molecule,
in response to IGF-I or IGF-II stimulation in  1C expressing
cells as compared with  1A expressing cells (Fig. 8 B). Our
results indicate that PI 3-kinase mediates  1C integrin effect
on cell adhesion to LN-1 in response to IGF.
Inhibition of IGF-IR prevents IGF-stimulated cell 
adhesion to LN-1
To confirm a direct involvement of IGF-IR in IGF-stimu-
lated cell adhesion to LN-1 in the presence of  1C integrin,
CHO cells expressing  1A or  1C were transiently trans-
fected with 486/STOP, a dominant negative form of IGF-
IR, known to inhibit IGF-IR signaling (Dunn et al., 1998).
As shown in Fig. 9 A, enhanced cell adhesion to LN-1 in
the presence of IGF-II in  1C integrin expressing CHO
cells was completely prevented by transfection of 486/
STOP, as compared with vector alone. The expression level
of the mutant receptor was analyzed in culture medium and
found comparable in  1A and  1C expressing cells trans-
fected with 486/STOP (unpublished data). Additional evi-
dence confirming the involvement of IGF-IR in adhesion
to LN-1 of PC3 cells expressing  1C was that an antibody
known to inhibit IGF-IR,  -IR3, prevented cell adhesion
to LN-1 in the presence of IGF-I, whereas ni-mIgG had no
effect (Fig. 9 B). This effect was specific to LN-1 because
no differences were observed when the cells were attached
to FN (Fig. 9 C). In conclusion, IGF-IR binding to IGF is
Figure 8. PI 3-kinase mediates IGF-stimulated adhesion to LN-1. 
(A)  1C-CHO clones were transiently transfected with vector alone 
(pcDNA3), wt-p85, or DNp85. Cells were cultured in the absence of 
tet for 48 h. 1.5   10
5 cells were plated per well coated with LN-1 
and incubated for 2 h at 37 C in the presence or in the absence of 
100 ng/ml IGF-II. Cells were washed, fixed, and stained with  -gal. 
Attachment of cells transfected with PI 3-kinase cDNA was expressed 
as percentage (average and SD) of the number of attached cells that 
were transfected with vector alone, set at 100. Data are expressed as 
mean   SEM. (B)  1A- or  1C-CHO clones were stimulated with IGF-I 
or IGF-II for 10 min, lysed and immunoblotted with Ab to Akt or Ab 
to phospho-Akt. Experiments were repeated at least twice with similar 
results. Results using representative clones are shown.
Figure 9. IGF binding to IGF-IR mediates adhesion of  1C expressing 
cells to LN-1. (A)  1A- and  1C-CHO clones were transiently trans-
fected with 486/STOP or vector alone. Cells were cultured in the 
absence of tet for 48 h. Cells were plated on either LN-1 or FN and 
incubated for 2 h at 37 C in the presence or in the absence of IGF-II. 
After incubation, cells were fixed and stained with  -gal. The 
number of attached cells transfected with 486/STOP cDNA was 
expressed as percentage of the number of attached cells transfected 
with vector alone, set at 100. (B and C)  1C- and  1A-PC3 clones 
were cultured in the absence of tet for 48 h. Cells were plated on 
BSA or LN-1 (B) or FN (C) at 37 C for 2 h in the presence or in the 
absence of IGF-I or  -IR3 or ni-mIgG. The experiments were re-
peated at least three times with similar results. Data are expressed 
as mean   SEM. 1 integrins and IGF-IR role in cell adhesion | Goel et al. 415
necessary to achieve maximal levels of cell adhesion to LN-1
in response to IGFs.
Discussion
The novelty of this work is that  1 integrin modulation of
IGF-IR functions is controlled by the  1 cytodomains that
recruit specific IGF-IR downstream effectors, either IRS-1
or the Gab1–Shp2 phosphatase complex, to the cell surface.
The finding that the association between  1A integrins
and IGF-IR regulate cell adhesion to a basement membrane
protein in response to IGF stimulation without affecting cell
proliferation or tumor growth, is novel. Although it was
known that integrins and growth factor receptors act syner-
gistically and are associated, it was not known that their
cross-talk determines the specificity of their activities (Ya-
mada and Even-Ram, 2002). The relevance of this work is
that the  1A–IGF-IR complex by limiting cancer cell adhe-
sion to the basement membrane, presumably allows the
tumor mass to expand and invade. A direct involvement
of IGF-IR in cell adhesion to LN has been shown earlier
(Dunn et al., 1998) supporting the evidence of a synergistic
and overlapping activity of integrins and IGF-IR in cell ad-
hesion. Our discovery was made possible by the serendipi-
tous finding that  1C, a  1A cytoplasmic variant that does
not associate with IGF-IR, increases cell adhesion to LN-1.
This variant form causes disruption of the  1A–IGF-IR asso-
ciation via a 25–amino acid domain which is uniquely
found in the  1C integrin. Several studies have demonstrated
that structural differences in the intracellular domains are
expected to be important determinants of the specificity of a
variety of integrin-mediated events (Fornaro and Languino,
1997). Although the cytodomain was not believed to af-
fect ligand specificity, our data prove that the integrin cyto-
domain affects ligand specificity in a substrate-dependent
manner. We show an inhibitory effect on IGF-IR activa-
tion without a wide change in integrin ligand binding, be-
cause cell adhesion to FN is unaffected in response to  1C
expression.
Here, as shown in Fig. 10, we demonstrate that the  1A–
IGF-IR complex preserves IGF-IR phosphorylation and as-
sociation with IRS-1, a molecule necessary to promote stim-
ulation of IGF-IR signaling pathways important for cell
proliferation and transformation (Reiss et al., 2000). In con-
trast,  1C does not associate with either IGF-IR or with IRS-1
and this results in failure to respond to a canonical IGF
stimulation. The  1C integrin inhibits IGF-stimulated tyro-
sine phosphorylation of IGF-IR and cell proliferation, as
well as tumor growth by associating with Gab1, and increas-
ing phosphorylation of Gab1. Gab1, a member of the IRS-1
family of adaptor proteins, is known to be phosphorylated in
response to several growth factor receptors’ activation, en-
hances cell growth and cell transformation, but has also a
negative role on cell survival through interaction with the
Shp2 tyrosine phosphatase (Gu and Neel, 2003; Holgado-
Madruga and Wong, 2003).  1C is likely to achieve the goal
of preventing IGF-IR and IRS-1 tyrosine phosphorylation
via activation of Gab1 and consequent recruitment of a
Figure 10. A model for the biological effects of the cross-talk between IGF-IR and  1 integrins. This model shows that the  1C integrin 
forms a complex with and activates Gab1/Shp2; this results in recruitment of Shp2 to IGF-IR and consequently, IGF-IR dephosphorylation. 
The signaling events stimulated by  1C expression results in increased cell adhesion to laminin, reduced cell proliferation and inhibition of tumor 
growth. When down-regulation of  1C occurs, IGF-IR remains tyrosine phosphorylated and associated with  1A integrin, and this results in 
increased tumor growth and cell proliferation, but in reduced cell adhesion to LN.416 The Journal of Cell Biology | Volume 166, Number 3, 2004
Gab1 binding protein, Shp2 (Gu and Neel, 2003), to IGF-
IR and IRS-1 (Myers et al., 1998). Gab1 activates PI
3-kinase, a molecule known to mediate cell adhesion by in-
hibiting the tyrosine phosphorylation of IRS-1 (Reiss et al.,
2001). PI 3-kinase is a downstream effector that mediates
IGF-IR as well as integrin-stimulated signaling; PI 3-kinase
activation requires Shp2 in some pathways activated by re-
ceptor-tyrosine-kinases such as IGF-IR and PDGF receptor,
but not by others such as EGF receptor (Reiss et al., 2001;
Neel et al., 2003; Tai et al., 2003). Our data show that both
Shp2 and PI 3-kinase mediate  1C-Gab1 effect on cell ad-
hesion. On the same line, a previous set of studies by
Clemmons’s group had shown that inhibition of  V 3 inte-
grin binding to its ligands prevents IGF-stimulated tyrosine
phosphorylation of IGF-IR and IRS-1 as well as cell prolifer-
ation to occur via Shp2 activation (Zheng and Clemmons,
1998). In contrast, this is the first work showing Gab1 re-
cruitment to the cell surface by integrins, because Gab1 has
only been shown to bind different growth factor receptors
(Gu and Neel, 2003).
Neoplastic cells have a surrounding matrix markedly dif-
ferent from the ECM surrounding normal cells (Parise et al.,
2000). In prostate cancer, like in breast carcinoma, a com-
plete loss of basement membranes has been described even
in well-differentiated tumors affecting its various compo-
nents including LN-1 (Fuchs et al., 1989; Nerlich et al.,
1998). LN-1 is found in normal human prostate glands
(Cress et al., 1995; Davis et al., 2001; Brar et al., 2003) and
in adult mouse prostate (Falk et al., 1996), but its expression
is lost in basement membranes surrounding primary carci-
noma and metastatic lymph node lesions (Brar et al., 2003).
Although normal tissues display expression of both  1C and
LN-1, down-regulation of both molecules occurs during
prostate cancer progression (Fornaro et al., 2001b), indicat-
ing that disruption of basement membranes and dysregula-
tion of integrin variant expression are coordinated events in
neoplastic transformation and that their expression is essen-
tial to sustain IGF stimulation of cell adhesion. Indeed, as-
sembly of LN polymers requires expression of the LN recep-
tor  1 integrin (Bouvard et al., 2001).
Further elucidation of the role of integrin–IGF-IR associ-
ation as well as of their downstream signaling pathways will
provide a better understanding of the mechanisms that con-
tribute to prostate cancer progression.
Materials and methods
Reagents and antibodies
Mouse LN-1 and lipofectamine 2000 were purchased from Invitrogen; BSA
was purchased from Sigma-Aldrich; recombinant human IGF-I was pur-
chased from R&D Systems; and IGF-II was purchased from Austral Biolog-
ics. Human FN was purified as described previously (Fornaro et al., 2003).
The following murine mAbs were used: to human  1 integrin TS2/16
(American Type Culture Collection); K-20 (Immunotech); P4C10 (CHEMI-
CON International, Inc.); 13 and clone 18 to  1 integrin (BD Biosciences);
7D5/BF10 to  1C integrin (Fornaro et al., 2001a); to chicken  1 integrin
W1B10 (Sigma-Aldrich); CSAT (Developmental Studies Hybridoma Bank
[DSHB]); to hamster  1 integrin 7E2 (DSHB). In addition, mAb to FLAG
(Sigma-Aldrich); mAb 12CA5 to HA (American Type Culture Collection);
1C10 to vascular endothelial surface protein (Life Technologies);  -IR3 to
IGF-IR (Oncogene); PY20 to phosphotyrosine (Santa Cruz Biotechnology,
Inc.); rat mAb to  6 GoH3 (CHEMICON International, Inc.). The following
rabbit polyclonal Abs were used: to IGF-IR-  (Santa Cruz Biotechnology,
Inc.); to Gab1 and to IRS-1 (Upstate Biotechnology); to hIGF-II (Pepro-
Tech); to Shp2 (Santa Cruz Biotechnology, Inc.); to phospho-Akt (Ser 473),
to Akt, to phospho-Shp2 (Tyr542; Cell Signaling); to ERK1 (Santa Cruz Bio-
technology, Inc.); to LN-1 described previously (Tsiper and Yurchenco,
2002; provided by P. Yurchenco, Robert Wood Johnson Medical School,
Piscataway, NJ). Non-immune Abs were ni-mIgG (Pierce Chemical Co.),
ni-rIgG and mIgM (Sigma-Aldrich), and rtIgG (Cappel).
Cell lines and transfectants
Normal human PrEC cells were obtained from Clonetics and maintained
as the manufacturer recommended. SV40 immortalized nontumorigenic
human prostate epithelial 267B1 and pRNS-1-1 cells were grown in kera-
tinocyte serum-free medium with 5 ng/ml human recombinant EGF and
0.05 mg/ml bovine pituitary extract (Parda et al., 1993; Peehl et al., 1997).
CHO stable cell transfectants expressing either human  1A or  1C inte-
grin were cultured as described previously (Fornaro et al., 2000). PC3 sta-
ble cell transfectants expressing chimeric  1A (clones 8 and 11) or  1C
(clones 17 and 19) integrin (chicken extracellular and human intracellular)
were generated using the tet-regulated expression system and cultured as
described previously (Fornaro et al., 2003). CHO- 1A, CHO- 1C, PC3- 1A,
and PC3- 1C clones were cultured for 48 h in growth medium in the ab-
sence of 1  g/ml tet to induce the expression of  1A or  1C integrin. R 
cells, mouse embryo fibroblasts obtained from IGF-IR knockout mice; and
R  cells, previously established by stably transfecting R  cells with the
human wild-type IGF-IR cDNA (Sell et al., 1994), provided by R. Baserga
(Thomas Jefferson University, Philadelphia, PA).
Integrin surface expression was analyzed by FACS
® as described previ-
ously (Fornaro et al., 2000, 2003). The pECE- 1COM plasmid containing
the  1 integrin area of the cytoplasmic domain shared by  1A and  1C trun-
cated at threonine residue 777, has been described previously (Retta et al.,
1998; provided by G. Tarone, University of Torino, Torino, Italy). CHO
cells were electroporated using 10  g pECE- 1COM along with 1  g
pFneo. G418-resistant clones were pooled and analyzed for cell surface
expression of human  1COM integrin by FACS
® using TS2/16 or 12CA5, as
a negative control, as described previously (Fornaro et al., 2000).
The  1C nucleotide sequence (Languino and Ruoslahti, 1992) was used
to design the RZ specific for the  1C cytoplasmic domain. A double-
stranded DNA encoding the RZ- 1C was obtained by annealing two syn-
thetic single-stranded oligodeoxyribonucleotides containing flanking ClaI
restriction sites and spanning a 55-bp sequence. The resulting double-
stranded DNA encoding the RZ- 1C was subcloned into the ClaI site of the
mammalian expression vector pBJ-1 and its sequence is as follows: 5 -
cgCGGTTTACCCTGTGCAAAGCAGGAGTGCCTGAGTAGTCAGAGAGA-
CAGCGGGT-3 . Lowercase letters correspond to the restriction sites,
whereas the underlined sequence corresponds to  1C regions (2420-2434
and 2437-2451) flanking the sequence encoding the catalytic domain of
the RZ. The RZ activity was initially tested in in vitro cell-free assays using
32P-labeled  1C mRNA.
Prostate tumor growth
PC3- 1A and PC3- 1C transfectants were induced to express  1A or  1C inte-
grin. Cells were detached using 0.05% trypsin/0.53 mM EDTA, washed,
and resuspended in RPMI. Cells (10
6) were inoculated subcutaneously into
the flank of 6–8-wk-old male athymic Balb/c mice (Charles River Laborato-
ries). Mice were given water supplemented with 5% sucrose or 5% sucrose
plus 100  g/ml tet to regulate the exogenous  1 integrin expression. Tumor
size was determined using a caliper every other day. Tumor volume was
calculated using the formula (vol   0.5236   [width]
2   [length]) and ex-
pressed as tumor volume in cubic millimeters. 10 mice/group were used in
each experiment.
Transient transfection
All transient transfections were performed using Lipofectamine 2000. R 
and R  cells were transiently transfected with 2  g pCMV- -galactosidase
( -gal) and either 10–30  g pBJ- 1A or 20–30  g pBJ- 1C. CHO clones ex-
pressing  1A or  1C were transiently transfected with 2  g  -gal and either
20  g pCMV-HA-wt-Shp2 or 20  g pCMV-FLAG-Shp2 C/S (Zhang et al.,
2002) cDNA, provided by B. Neel (Beth Israel Deaconess Medical Center
and Harvard Medical School, Boston, MA).  1C-CHO clones were tran-
siently transfected with 2  g  -gal and 20  g of vector alone (pcDNA3),
20  g DNp85 (pSR - p85 ) or 20  g wt-p85 (Hara et al., 1994) cDNA,
provided by R. Kalb (Yale University School of Medicine, New Haven,
CT). Cells were cultured in the absence of tet in growth medium for 48 h.
In a separate set of experiments,  1A- and  1C-CHO clones were transiently
transfected with 2  g  -gal and either 20  g of vector alone (pcDNA3) or
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were cultured in the absence of tet in growth medium for 48 h. 267B1
cells were transiently transfected with 2  g  -gal and either 20  g pBJ1 or
20  g pBJ1-RZ- 1C cDNA. Cells were harvested 48 h after transfection and
used in adhesion assays as described below. In parallel, transfected cells
were seeded on 48-well plates and stained for  -gal expression to deter-
mine transfection efficiency as described previously (Manes et al., 2003).
Cell adhesion assay
CHO cell adhesion to LN-1 or BSA (100  g/ml), or 10  g/ml FN was per-
formed as described previously (Languino et al., 1993) in the presence or
absence of 100 ng/ml IGF-II. Where specified, cells were incubated with
either Ab to IGF-II or, as a negative control, 0.1  g/ml ni-rIgG for 1 h
on ice.
Alternatively, cell adhesion assays of 267B1, CHO clones, R  and R 
cells to BSA or LN-1 (100  g/ml), or 10  g/ml FN after being transiently
transfected with cDNA constructs were performed by incubating cells with
the coated substrates for 2 h at 37 C in the presence or in the absence of
IGF-II or IGF-I (100 ng/ml). After adhesion,  -gal staining was performed as
described previously (Manes et al., 2003).
For PC3 clones and PrEC, 80,000 cells were allowed to adhere to plates
coated with different substrates as indicated in each figure legend for 2 h at
37 C in the presence or in the absence of IGF-I or IGF-II (100 ng/ml),  -IR3
or ni-mIgG (10 or 30  g/ml), Ab to LN-1 or ni-rIgG (30 or 100  g/ml), or
GoH3 or rtIgG (20  g/ml). Cells were fixed and stained with crystal violet
(0.5%) and OD was measured at 630 nm (Manes et al., 2003).
Analysis of  1 integrin association with IGF-IR, IRS-1, or Gab1
PC3 and CHO clones were induced to express  1A or  1C integrin. Cells
were detached and stimulated with 100 ng/ml IGF-I for 10 min, washed
and lysed. Proteins were immunoprecipitated by incubating with K-20 and
protein A-Sepharose. Immunocomplexes were dissociated and reprecipi-
tated with Ab to IGF-IR or ni-rIgG as described previously (Fornaro et al.,
2000). Proteins were separated by SDS-PAGE and immunoblotted using
Abs to  1 integrin (clone 18), to IGF-IR- , to IRS-1 or to Gab1. As control,
expression levels of IRS-1 or  1 integrin or IGF-IR were analyzed using re-
spective Abs. Immunoprecipitation of chicken  1 integrin was performed
using CSAT Ab as described previously (Marcantonio and Hynes, 1988).
CHO clones expressing wild-type full-length  1A or different truncated
forms of  1 integrin were allowed to grow to 70% confluency. The cells
were lysed and association between  1 integrin and IGF-IR was studied as
described above.
Analysis of tyrosine phosphorylation of IGF-IR, IRS-1, or Gab1
PC3 or CHO clones were detached and trypsin was neutralized with
soybean trypsin inhibitor. Cells were stimulated with 100 ng/ml IGF-I,
washed, lysed, and proteins were immunoprecipitated with IGF-IR, IRS-1
or Gab1 Abs and protein A-Sepharose. Immunoprecipitates were then sep-
arated by SDS-PAGE under reducing conditions and immunoblotted with
PY20, IGF-IR- , IRS-1 or Gab1, and visualized by ECL.
Immunoblotting
pRNS-1-1 and 267B1 cells were grown to 70% confluency, lysed, and im-
munoblotted with mAb to  1C or mIgM (5  g/ml) as described previously
(Fornaro et al., 2001a). 267B1 cells transiently transfected with RZ- 1C or
vector were lysed and immunoblotted with mAb to 5  g/ml  1C or Ab to
Akt or Ab to 0.2  g/ml IGF-IR (Fornaro et al., 2000). CHO clones express-
ing  1A or  1C were starved overnight, stimulated with IGF-I or IGF-II for 10
min, lysed, and immunoblotted with Ab to Akt or Ab to phospho-Akt (For-
naro et al., 2000). CHO clones expressing  1A or  1C were transiently trans-
fected with HA-tagged wt-Shp2 or FLAG-tagged Shp2 C/S. Cells were
lysed and immunoblotted with Ab to 0.5  g/ml HA or Ab to 0.5  g/ml
FLAG or Ab to 0.2  g/ml ERK1.
Analysis of Gab1 association with either Shp2 or phospho-Shp2
CHO clones were induced to express  1A or  1C integrin. Cells were de-
tached and stimulated with 100 ng/ml IGF-I for 10 min, washed and lysed;
proteins were immunoprecipitated by incubating with Ab to 1  g Gab1
and protein A-Sepharose (Fornaro et al., 2000). Proteins were separated by
SDS-PAGE and immunoblotted with Ab to 0.2  g/ml Gab1 or 0.2  g/ml
Shp2 or phospho-Shp2 (1:1,000 dilution).
SRB assay
Proliferation was measured using SRB assay. PC3 clones were induced to
express  1A or  1C integrin, serum starved for 12 h, detached, and seeded
on 96-well plates (7.5   10
3 cells per well) in the presence or in the ab-
sence of IGF-I or IGF-II (100 ng/ml). Cells were incubated for 72 h without
a medium change. After incubation, cells were fixed with 10% TCA at 4 C
for 1 h, washed five times with tap water and stained with 0.2% SRB for 15
min. The plates were then washed five times with 1% acetic acid, dried,
and stained cells in each well were solubilized with 10 mM Tris base. The
absorbance in each well was measured at 540 nm. SRB results were con-
firmed by cell counting.
Statistical analysis
Differences in cell adhesion to LN were measured using t test. Tumor vol-
ume was measured for each mouse on multiple days; to analyze the data,
a mixed-effect general linear model for repeated measurements was ap-
plied. Analysis was operated using SAS (version 8.2; SAS Institute, Inc.).
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